AARD
Aardvark Therapeutics, Inc. Common Stock
NASDAQ: AARD · HEALTHCARE · BIOTECHNOLOGY
$5.21
-6.80% today
Updated 2026-04-29
Market cap
$113.66M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.93
Dividend yield
—
52W range
$3 – $18
Volume
0.3M
Aardvark Therapeutics, Inc. Common Stock (AARD) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating cash flow | $-10.54M | $-5.82M | $-18.09M | $-54.17M |
| Capital expenditures | $0.00 | $0.00 | $109000.00 | $95000.00 |
| Depreciation | $110000.00 | $97000.00 | $16000.00 | — |
| Stock-based comp | $412000.00 | $313000.00 | $439000.00 | $3.95M |
| Free cash flow | $-10.54M | $-5.82M | $-18.20M | $-54.27M |
| Investing cash flow | $-1.00M | — | $-12.00M | — |
| Financing cash flow | $225000.00 | $0.00 | $81.99M | — |
| Dividends paid | — | — | — | — |
| Share repurchases | — | — | — | — |
| Debt repayment | — | — | — | — |
| Net change in cash | — | — | — | — |